Diagnosis and management of Acanthamoeba keratitis

@article{Hammersmith2006DiagnosisAM,
  title={Diagnosis and management of Acanthamoeba keratitis},
  author={Kristin M. Hammersmith},
  journal={Current Opinion in Ophthalmology},
  year={2006},
  volume={17},
  pages={327–331}
}
  • K. Hammersmith
  • Published 1 August 2006
  • Medicine
  • Current Opinion in Ophthalmology
Purpose of review This paper reviews the literature generated on Acanthamoeba keratitis since 1998. Recent findings Acanthamoeba infections may be on the rise. Contact lenses are the biggest risk factor for their development. Silicone hydrogel lenses are increasingly prescribed and may be ‘more sticky’ to Acanthamoeba organisms. Orthokeratology for the treatment of myopia has been associated with many new cases of Acanthamoeba keratitis. Daily disposable contact lenses are the safest form of… 
Acanthamoeba keratitis: diagnosis and treatment update 2009.
An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment
TLDR
Novel molecular approaches such as proteomics, RNAi and a consensus in the diagnostic approaches for a suspected case of Acanthamoeba keratitis are proposed and reviewed based on data which have been compiled after years of working on this amoebic organism.
Non-contact lens related Acanthamoeba keratitis
TLDR
Epidemiology, clinical features, diagnosis, and treatment of Acanthamoeba keratitis with special focus on the disease in nonusers of contact lenses (CLs), based on authors' experience and review of published literature is described.
PERSPECTIVE Acanthamoeba Keratitis: Diagnosis and Treatment Update 2009
TLDR
The scleritis associated with AK is rarely associated with extracorneal invasion and usually responds to systemic anti-inflammatory treatment combined with topical biguanides, and Therapeutic keratoplasty retains a role for therapy of some severe complications of AK but not for initial treatment.
Diagnosing Acanthamoeba keratitis: what does the future hold?
TLDR
Topical and systemic anti-inflammatory treatment is needed for the management of severe inflammatory complications and topical biguanides are the only consistently effective drugs in vitro, if not always in vivo.
An Atypical Presentation of Acanthamoeba Keratitis in a Patient With Keratoconus Treated Briefly With Topical Anesthetic
TLDR
Katoconic patients may have atypical presentations of acanthamoeba keratitis, which may delay diagnosis and institution of medical therapy, and brief use of topical anesthetics may further complicate the clinical picture.
Update on Acanthamoeba Keratitis: Diagnosis, Treatment, and Outcomes
TLDR
Early diagnosis and treatment are required to effectively manage this condition and there is often a poor prognosis because of a significant delay in diagnosis and frequently a lack of effective medical management.
Oral Miltefosine as Adjunctive Treatment for Recalcitrant Acanthamoeba Keratitis.
TLDR
This case shows resolution of recalcitrant Acanthamoeba keratitis with oral miltefosine in an immunocompetent patient, and further clinical evidence would be needed to possibly incorporate this medication in the antiamoebic armamentarium.
A descriptive case of persistent Acanthamoeba keratitis: raising awareness of this complex ocular disease
TLDR
A 73-year-old female admitted to hospital due to vision impairment of her left eye and treated with antivirals was diagnosed with Acanthamoeba keratitis, which can be easily misdiagnosed due to the similarities in the clinical presentation to other, much more common ocular pathogens.
Acanthamoeba keratitis and contact lens wear
TLDR
Six cases of contact lens‐related Acanthamoeba keratitis that occurred in Australia and New Zealand over a three‐year period are described and patients who wear contact lenses must be thoroughly educated about the proper use and care of the lenses.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 55 REFERENCES
Treatment of Acanthamoeba keratitis.
TLDR
Early diagnosis and wide epithelial debridement are important elements in the successful treatment of Acanthamoeba keratitis and surgical intervention should be avoided until a medical cure has been achieved.
Advances in the Management of Keratomycosis and Acanthamoeba Keratitis
TLDR
Although there has been steady progress in the management of both infections, continued research is the way to define more effective medical and surgical therapy.
The Epidemic of Acanthamoeba Keratitis: Where Do We Stand?
TLDR
The recent epidemic of Acanthamoeba keratitis provides a valuable lesson on how a new technology can be associated with unforeseen complications and exemplifies how rapid dissemination of epidemiologic information can aid in controlling an emergent epidemic.
Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine
TLDR
The combination of topical chlorhexidine and propamidine was very effective for treating Acanthamoeba keratitis provided the drugs were continued for a sufficient period and no drug toxicity or resistance of Acanthameba isolates was observed in the 12 treated patients.
Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis
TLDR
Overall visual outcome was poor with no statistical difference between cases diagnosed within 30 days (early) or 30 days after (late) start of symptoms, thought to be the largest series of cases of Acanthamoeba keratitis in non-contact lens wearers.
An Atypical Presentation of Acanthamoeba Keratitis in a Noncontact Lens Wearer
TLDR
A 49-year-old man who did not have a history of wearing contact lenses and who developed a rapidly progressive course of Acanthamoeba keratitis was diagnosed clinically and histopathologically within 1 week of onset of symptoms.
Acanthamoeba keratitis update—incidence, molecular epidemiology and new drugs for treatment
TLDR
A number of guanidines have been identified in this paper that could be usefully pursued as part of combination chemotherapy along with the alkylphosphocholines and further research is needed on more effective combination chemotherapy.
Treatment of Advanced Acanthamoeba Keratitis With Deep Lamellar Keratectomy and Conjunctival Flap
TLDR
Deep lamellar keratectomy with a conjunctival flap is a suitable approach to help control the infection and to help relieve pain in patients with advanced Acanthamoeba keratitis.
The Role of Topical Corticosteroids in the Management of Acanthamoeba Keratitis
TLDR
P prudent use of corticosteroids in selected patients with severe pain not responsive to analgesics or severe corneal or anterior chamber inflammation appears justified, and outcome after medical therapy between the groups was not significantly different.
Delay in diagnosis and outcome of Acanthamoeba keratitis
TLDR
A diagnostic delay of less than 18 days between onset of symptoms and start of anti-amoebic treatment results in a better final VA after medical treatment and obviates the need for urgent and elective penetrating keratoplasty.
...
1
2
3
4
5
...